Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GOSS | AZN | AMGN | GILD | GSK |
| Company | Gossamer Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.10 | 206.60 | 372.01 | 150.58 | 59.87 |
| High | 2.22 | 207.69 | 377.00 | 153.26 | 60.05 |
| Low | 2.06 | 204.05 | 371.39 | 150.09 | 59.33 |
| Latest | 2.12 | 204.81 | 375.98 | 151.29 | 59.65 |
| Change | +0.01 | -1.64 | +0.48 | +0.17 | -0.72 |
| % Change | +0.47% | -0.79% | +0.13% | +0.11% | -1.19% |
| Volume | 5,669,120 | 1,281,409 | 1,748,850 | 3,874,874 | 4,590,258 |
| 20-Day Average Volume | 5,511,062 | 2,889,476 | 2,959,155 | 8,249,162 | 6,595,662 |
| Previous Close | 2.11 | 206.45 | 375.50 | 151.12 | 60.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.38 | 194.54 | 360.92 | 147.12 | 56.06 |
| 20-Day Raw Stochastic | 5.81% | 73.27% | 74.41% | 78.51% | 83.58% |
| 20-Day Relative Strength | 38.00 | 62.11 | 61.15 | 63.98 | 68.28 |
| Weighted Alpha | +46.64 | +46.71 | +31.57 | +48.33 | +74.08 |
| Today's Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 64% Buy | 88% Buy | 96% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.05% since 02/12/26 | +0.11% since 02/12/26 | +1.88% since 02/12/26 | -0.11% since 02/12/26 | +1.71% since 02/12/26 |
| Low | 2.06 on 02/20/26 | 204.05 on 02/20/26 | 361.71 on 02/13/26 | 150.09 on 02/20/26 | 58.56 on 02/13/26 |
| High | 2.49 on 02/13/26 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | -18.85% since 01/20/26 | +13.82% since 01/20/26 | +12.71% since 01/20/26 | +22.15% since 01/20/26 | +24.95% since 01/20/26 |
| Low | 2.06 on 02/20/26 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 47.77 on 01/21/26 |
| High | 3.00 on 01/22/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | -32.15% since 11/20/25 | +15.43% since 11/20/25 | +11.01% since 11/20/25 | +21.32% since 11/20/25 | +29.13% since 11/20/25 |
| Low | 2.06 on 02/20/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 46.47 on 11/21/25 |
| High | 3.87 on 12/15/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +8.21% since 08/20/25 | +27.13% since 08/20/25 | +25.85% since 08/20/25 | +27.72% since 08/20/25 | +48.59% since 08/20/25 |
| Low | 1.99 on 08/21/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 3.87 on 12/15/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 488,372 | 323,550,432 | 202,420,032 | 187,491,552 | 124,037,000 |
| Shares Outstanding, K | 231,456 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 114,700,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -56,530,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 13,290,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -48,220,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 1.93 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/05/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 03/12/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.38 | 18.74 | 13.54 |